Opportunity Information: Apply for PAR 23 067

The National Institutes of Health (NIH), through the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project, is offering an exploratory research grant opportunity focused on strengthening the research toolkit available for Down syndrome (DS). This funding opportunity, PAR-23-067, uses the R21 mechanism and is strictly preclinical in nature (clinical trials are not allowed). The core aim is to spur innovative, early-stage projects that either create new animal models, significantly improve existing DS-relevant models, or generate closely related biological materials that make DS research more informative, rigorous, and reproducible. A major emphasis is that the models and materials supported must be clearly useful for DS-focused basic science or targeted mechanistic studies in areas considered highly relevant to Down syndrome.

The opportunity is intentionally broad in the kinds of approaches it will consider, as long as they push the field forward in practical and shareable ways. Examples of encouraged directions include developing or refining a range of animal models and genetic resources that better represent DS biology, creating detailed atlases that map tissues or systems at single-cell or even subcellular resolution, and building or applying advanced informatics tools. NIH explicitly notes interest in modern computational approaches, including artificial intelligence and machine learning, especially where they help analyze complex datasets, integrate results across platforms, or improve how model-based findings are interpreted and reused. Another recurring theme is integration: projects that connect multiple model systems, multiple technologies, or complementary datasets in ways that improve confidence in preclinical conclusions and enable stronger cross-study comparisons are within scope.

In addition to building new resources, this announcement highlights improving access to information about animal models and their use in DS research. In practice, that can mean efforts that make model characteristics clearer, usage more standardized, or data more findable and interpretable to other researchers. The underlying goal is to reduce fragmentation in preclinical DS work by making models, associated biological materials, and the knowledge generated from them easier to evaluate, replicate, and build upon.

Eligibility is broad and includes many types of U.S.-based and U.S.-affiliated organizations: state, county, city, township, and special district governments; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; independent school districts; public and state-controlled universities; private institutions of higher education; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses. The announcement also calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal government agencies, and U.S. territories or possessions. At the same time, it places clear limits on foreign involvement: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, and non-U.S. components of U.S. organizations are not eligible. However, foreign components, as defined by the NIH Grants Policy Statement, are allowed, meaning certain types of international collaboration can be included when properly justified and structured under NIH policy.

Key administrative details include that this is a discretionary grant in the health-related funding area (CFDA numbers 93.351, 93.865, and 93.866). The opportunity was created on December 8, 2022, and lists an original closing date of January 7, 2026. The award ceiling is $200,000, reflecting the R21 program’s role in supporting exploratory, high-impact ideas that may be earlier in development than a full-scale R01 project. Overall, the program is designed to accelerate DS research by expanding and improving the preclinical model ecosystem, increasing the usefulness and accessibility of related biological resources, and encouraging data-rich, technology-forward approaches that raise the quality and reproducibility of DS-related preclinical science.

  • The National Institutes of Health in the health, income security and social services sector is offering a public funding opportunity titled "Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.351, 93.865, 93.866.
  • This funding opportunity was created on 2022-12-08.
  • Applicants must submit their applications by 2026-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 23 067

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health, Income Security and Social Services

Next opportunity: Rapid Translation of Epidemiological Findings into Interventions to Prevent Substance Use and Addiction (R61/R33 Clinical Trial Optional)

Previous opportunity: Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R61/R33 Clinical Trial Required)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 23 067

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 23 067) also looked into and applied for these:

Funding Opportunity
Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed) Apply for PAR 22 261

Funding Number: PAR 22 261
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) Apply for PAR 23 074

Funding Number: PAR 23 074
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $499,999
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) Apply for PAR 23 130

Funding Number: PAR 23 130
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
Population Dynamics Centers Research Infrastructure Program FY 2024 (P2C Clinical Trial Not Allowed) Apply for RFA HD 24 008

Funding Number: RFA HD 24 008
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed) Apply for PAR 23 114

Funding Number: PAR 23 114
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $325,000
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) Apply for PAR 23 160

Funding Number: PAR 23 160
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $100,000
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) Apply for PAR 23 159

Funding Number: PAR 23 159
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $275,000
Data Integration and Statistical Analysis Methods (DISAM) (U01 Clinical Trial Not Allowed) Apply for RFA HG 23 005

Funding Number: RFA HG 23 005
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $400,000
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) Apply for PAR 23 180

Funding Number: PAR 23 180
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDUL) (P50 Clinical Trial Not Allowed) Apply for RFA HD 24 005

Funding Number: RFA HD 24 005
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $1,000,000
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed) Apply for PAR 23 193

Funding Number: PAR 23 193
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATCH-IN) Implementation Science Coordinating Center (UM2 Clinical Trial Optional) Apply for RFA HD 24 009

Funding Number: RFA HD 24 009
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $1,250,000
National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 Clinical Trial Optional) Apply for RFA HD 24 010

Funding Number: RFA HD 24 010
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $1,100,000
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R01 Clinical Trial Optional) Apply for RFA MH 24 160

Funding Number: RFA MH 24 160
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R21 Clinical Trial Optional) Apply for RFA MH 24 161

Funding Number: RFA MH 24 161
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent
Diagnostic Centers of Excellence for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed) Apply for PAR 23 289

Funding Number: PAR 23 289
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $500,000
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) Apply for RFA MH 24 190

Funding Number: RFA MH 24 190
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $300,000
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed) Apply for PAR 23 296

Funding Number: PAR 23 296
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $275,000
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R21 Clinical Trial Optional) Apply for RFA MH 24 331

Funding Number: RFA MH 24 331
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: $275,000
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed) Apply for PAR 23 297

Funding Number: PAR 23 297
Agency: National Institutes of Health
Category: Health, Income Security and Social Services
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 067", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: